New gene test may help identify prostate cancer:
This article was originally published in Clinica
A new gene test could help doctors to detect prostate cancer more reliably from tissue samples, according to US researchers at the University of Michigan Medical School. The gene, called AMACR, was reported to be over-expressed in prostate cancer samples and may be a useful diagnostic biomarker in difficult-to-diagnose samples. Study leader, Mark Rubin, reported the gene test to be 97% sensitive and 100% specific for the disease. The findings are published in the Journal of the American Medical Association (April 3).
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.